June 8th 2021
Creso’s acquisition target Halucenex to extend clinical trials beyond veterans
June 3rd 2021
Bill passed: wide range of psychedelics could be made legal in the US
May 26th 2021
Creso Pharma’s Halucenex engages HeteroGeneity ahead of US entry
May 14th 2021
CPH further derisks acquisition as Halucenex adds to its psychedelics supply
May 6th 2021
Halucenex forms important partnership as psychedelics space heats
April 30th 2021
Revenues up 237%: Creso Pharma delivers strong quarter ahead of OTC listing
April 19th 2021
Move to legalisation of psychedelics could benefit CPH in the US
April 12th 2021
Creso Pharma’s target acquisition company announces expansion into other psychedelic compounds
Connect with us
